Aurobindo Pharma USA subsidiary Acrotech Biopharma has signed a definitive agreement to buy seven haematology and oncology drugs from Spectrum Pharmaceuticals for a consideration of up to $300m. The terms of the agreement involve upfront payment of $160m in cash in...
Acquired portfolio includes seven branded oncology injectable products which are currently being marketed. The acquisition also brings-in an experienced branded commercialinfrastructure in the USThe portfolio is expected to generate a revenue of around $100 million...
